Neuralstem is developing neural stem cell therapy and pharmaceuticals for the treatment of diseases and conditions of the CNS, including ALS, chronic spinal cord injury, chronic stroke, major depression…
http://www.neuralstem.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
1 seconds
16x16
32x32
Neuralstem, Inc.
9700 gre●●●●●●●● highway
roc●●●lle , MD, 20850
US
View this contact
Neuralstem, Inc.
Neuralstem, Inc.
9700 gre●●●●●●●● highway
roc●●●lle , MD, 20850
US
View this contact
Neuralstem, Inc.
Neuralstem, Inc.
9700 gre●●●●●●●● highway
roc●●●lle , MD, 20850
US
View this contact
BUY YOUR DOMAIN
25
YEARS
0
MONTHS
11
DAYS
NETWORK SOLUTIONS, LLC.
WHOIS : whois.networksolutions.com
REFERRED : http://networksolutions.com
PAGES IN
THIS WEBSITE
8
SSL
EXTERNAL LINKS
49
SITE IP
52.192.20.222
LOAD TIME
1.031 sec
SCORE
6.2
Neuralstem, Inc. (CUR) | neuralstem.com Reviews
https://neuralstem.com
Neuralstem is developing neural stem cell therapy and pharmaceuticals for the treatment of diseases and conditions of the CNS, including ALS, chronic spinal cord injury, chronic stroke, major depression…
Investor Relations :: Neuralstem, Inc. (CUR)
Neuralstem Announces Publication of a Study in Nature Medicine Showing Benefits of NSI-566 in a Primate Model of Spinal Cord Injury. Mar 13, 2018. Quarter Ended Sep 30, 2017. American Stock Transfer and Trust Company, LLC. Brooklyn, NY 11219. Dixon Hughes Goodman LLP. 809 Glen Eagles Court. Baltimore, MD 21286. 2018 Neuralstem, Inc.
neuralstem.com
Cell therapy and drug treatments in development
https://www.neuralstem.com/patient-info-treatments-in-development
Sign up for Breaking News Email Alerts. FDA-approved multi-center dose-escalation Phase II NSI-566/ALS clinical trial primarily evaluating safety concluded in 1Q15. Larger, controlled, registration directed NSI-566/ALS clinical trial expected to commence in 2016. More. NSI-566 Phase I / II trial for ischemic stroke commenced in December 2013, in collaboration with BaYi Brain Hospital in Beijing. Phase II controlled proof-of-concept study commencement expected in 2016. More. Preclinical phase with NSI-566...
Chronic Spinal Injury
https://www.neuralstem.com/cell-therapy-for-sci
Sign up for Breaking News Email Alerts. For Spinal Cord Injury. FDA-approved NSI-566/cSCI Phase I Safety Clinical Trial completed the last surgery in July 2015, with six-month post-observation period; FDA amended protocol to four patients total. NSI-566/Acute SCI Phase I/II trial awaiting IND approval. Rebuilding neural circuitry across and below the injury site. Direct injections into the spinal cord in and around the injury site. Nerve cell death within the spinal cord. Disruption of nerve pathways.
Creating a new class of neuroregenerative drugs…
https://www.neuralstem.com/pharmaceuticals
Sign up for Breaking News Email Alerts. Creating a New Class of Neurogenic Drugs. Unlimited numbers of cells for screening. Four patented first-in-class compounds. World's only human hippocampus neural stem cell lines. An entirely new approach to treating diseases. Using the Brain to Repair Itself. Assaults on neurons in the human hippocampus are now suspected to be linked to many devastating diseases of the mind and brain. Drugs that stimu. Late the generation of new neurons - an aspect of the healthy b...
Repairing and replacing damaged cells…
https://www.neuralstem.com/cell-therapy
Sign up for Breaking News Email Alerts. Repairing and Replacing Damaged Cells. Patented technology enables isolation. And expansion of human neural stem cells. Regionally specific cells are specialized, already suited to the task. Cells integrate with, and protect, the patient's spinal cord neurons. Cells believed to create new circuitry and express neuroprotective growth factors. There are two primary ways that these cells can provide therapeutic effects. We believe that Neuralstem's cells do both.
About Neuralstem
https://www.neuralstem.com/about-neuralstem
Sign up for Breaking News Email Alerts. Neuralstem's patented technology enables the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the potential treatment of central nervous system diseases and conditions. Neuralstem, Inc. 2016. Cognitive complication due to Diabetes. Website by inktank LLC.
TOTAL PAGES IN THIS WEBSITE
8
Bio Business News | Biomedical Engineering & Biotechnology News
http://www.biomedicalblog.com/category/business
Biomedical Engineering and Biotechnology News. RSS feed for this section. Immunotherapy Cancer Results Cause Pharma Stocks to Rise. Posted on 12 June 2013. Patients with advanced melanoma find success with experimental drugs developed to stimulate the immune response. Top pharmaceutical companies including Merck and Co., Bristol-Myers Squibb Inc., and The Roche Group present optimistic data to cancer specialists in Chicago. How does immunotherapy work? The market is bright for engineered antibodies. ...
Textos - RNTC - Rede Nacional de Terapia Celular
http://www.rntc.org.br/textos1.html
RNTC - Rede Nacional de Terapia Celular. Centros de Tecnologia Celular. Tire suas Dúvidas. A RNTC na Imprensa. Cientistas apostam em células-tronco em pesquisa para curar cegueira - BBC - 29/09/2015. A cirurgia faz parte de um projeto criado há uma década para tentar reverter a perda de visão em pacientes com degeneração macular. Dez pacientes com o tipo "úmido" da doença, considerado o mais grave, participarão dos testes. Funciona assim: quando uma célula está em contato com outra, mol&eac...Camundongos...
T.R. Winston & Company - Transactions
http://www.trwinston.com/transactions
Chanticleer Holdings, Inc. Prosetta Biosciences, Inc. Lilis Energy, Inc. Siskey Capital, LLC. Prosetta Biosciences, Inc. Tivorsan Pharmaceuticals, Inc. Synthesis Energy Systems, Inc. Preferred Voice, Inc. Insignia Systems, Inc. Incard Technology Resources, Inc. ProMetic Life Sciences Inc. Incard Technology Resources, Inc. Derycz Scientific, Inc. GammaCan International, Inc. Coda Octopus Group, Inc. QPC Lasers, Inc. Innovative Card Technologies, Inc. Recovery Energy, Inc. Emmaus Life Sciences, Inc.
Neurophotonics Coming to a Human Being Near You | Nutrition Wonderland
http://nutritionwonderland.com/2010/09/neurophotonicshuman-being
Neurophotonics Coming to a Human Being Near You. Sep 20, 2010 By: John Serrao. Neurophotonics, up close. Researchers at SMU are working with DARPA. The goal of the Neurophotonics Research Center is to develop a link compatible with living tissue that will connect powerful computer technologies to the human nervous system through hundreds or even thousands of sensors embedded in a single fiber. This program follows in the footsteps of DARPA’s ‘Revolutionizing Prosthetics’ Program. Whose goal was to have n...
Clients | M2Friend
http://www.marymoynihan.com/about/our-clients.html
Print and Graphic Design. We've had the pleasure of working with. Some amazing companies over the years:.
hopesanddreams4acure.blogspot.com
Hopes & Dreams Quilt Challenge: March 2014
http://hopesanddreams4acure.blogspot.com/2014_03_01_archive.html
Hopes and Dreams Quilt Challenge. Finding a Cure for ALS - One Quilt at a Time! Thursday, March 27, 2014. Bluebird of Happiness Smile Upon You. What a happy mail week it has been. Lots of packages filled with Hopes and Dreams quilts from all over the United States. Each package containing one or more quilts to help us reach our goal of 1,000 quilts by July 31, 2014. Then we received an enveloped addressed to Hopes and Dreams that contained this little gem! We included a new category in this years Hopes a...
Stem Cells and Hope in ALS: Part 2 | MDA/ALS Newsmagazine
http://alsn.mda.org/blogs/stem-cells-hope-als-part-2
MDA ALS Caregiver’s Guide. Everyday Life with ALS: A Practical Guide. Clinical Trials and Studies. Computer and Communication Tools. Low Tech and DIY. Ventilators and Respiratory Devices. Stem Cells and Hope in ALS: Part 2. By Clive N. Svendsen, Ph.D., and Geneviève Gowing, Ph.D. on Wed, 2013-05-29 05:00. Clive N. Svendsen, Ph.D. Geneviève Gowing, Ph.D. Replacing lost motor neurons. Neural stem cells (NSCs). And glial restricted precursors (GRPs). In 2003, ALS researchers published an article indicating ...
Kompetenznetzwerk Stammzellforschung NRW: Links
http://www.stemcells.nrw.de/en/links.html
Direkt zum Inhalt / to Content. Zum Hauptmenü / to Navigation. Latest News and Press. Useful weblinks sorted by topics. 1 General Information about Stem Cell Research. 4 International Stem Cell Networks, Organizations and Associations. 1 General view about stem cell research. Various articles about stem cells at Pubmed. Wwwncbi.nlm.nih.gov/. National Institutes of Health about Stem Cells. Ion Channel Media's survey of many aspects of stem cell research. The Niche at Nature. Stem cell debate in Germany.
Website Copy and Creation | Corporate Communications/PR
http://www.planetcommunications.us/2011/11/03/website-copy-and-creation
Global strategies. Nimble execution. Could This Be the End of Embryonic Stem Cell Research? Website Copy and Creation. November 3, 2011. Your website is the first thing most people see; it is your company’s face. Poorly explained or fuzzily positioned, and that’s what viewers be they investors, industry or media walk away with. Go to www.neuralstem.com. This entry was posted in Media. Could This Be the End of Embryonic Stem Cell Research? Leave a Reply Cancel reply. Subscribe to Receive Updates.
TOTAL LINKS TO THIS WEBSITE
49
neuralspecialists.com - neuralspecialists Resources and Information.
neuralsplash.com
Neuralstainkit
Find the best information and most relevant links on all topics related to neuralstainkit.com.
neural stem-cell
1950 (negotiable) Please contact us. This domain name is for sale at $1950 (negotiable). Contact batchev@comcast.net. Please watch the trailer of my movie at. A great comedy situated in the hippy years. groovy man, groovy!
Neural stem-cells
1950 (negotiable) Please contact us. This domain name is for sale at $1950 (negotiable). Contact batchev@comcast.net. Please watch the trailer of my movie at. A great comedy situated in the hippy years. groovy man, groovy!
Neuralstem, Inc. (CUR)
Innovating Nervous System Therapies. Neuralstem (NASDAQ: CUR) is a biopharmaceutical company researching and developing novel treatments for nervous system diseases based on our neural stem cell technology. NSI-189 is a new chemical entity in clinical development for major depressive disorder (MDD) and in preclinical development for Angelman syndrome, cognitive impairment, neuropathy associated with Type 1 and Type 2 diabetes, and stroke. Apr 10, 2018 at 12:00 AM EDT. Phase 1 Phase complete. Phase 3 Phas...
Under construction
neuralstemcells.com
neuralstemcelltherapies.com - Registered at Namecheap.com
This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! The Sponsored Listings displayed above are served automatically by a third party. Neither Parkingcrew nor the domain owner maintain any relationship with the advertisers.
neuralstemcelltherapy.com - Registered at Namecheap.com
This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! The Sponsored Listings displayed above are served automatically by a third party. Neither Parkingcrew nor the domain owner maintain any relationship with the advertisers.
neuralstimulator.info
If you are the owner of this domain name, click here to verify. Review our Privacy Policy.
SOCIAL ENGAGEMENT